文献速递创伤与烧伤复苏、休克与脓毒症

在高致死性猪出血模型中探究自动化部分REBOA策略期间出血、凝血与凝血病的关系

INVESTIGATING THE RELATIONSHIP BETWEEN BLEEDING, CLOTTING, AND COAGULOPATHY DURING AUTOMATED PARTIAL REBOA STRATEGIES IN A HIGHLY LETHAL PORCINE HEMORRHAGE MODEL.
PubMed 文献 · Shock · 2024-06-11
一句话结论猪肝横断出血模型中,pREBOA与iREBOA的TEG参数无显著差异,但pREBOA组输血需求显著减少且血流动力学更稳定,作者认为可能有证据支持优先使用pREBOA。

研究在Yorkshire猪(每组n=8)肝横断非控制性出血模型中比较自动化部分REBOA(pREBOA)、间歇REBOA(iREBOA)与无球囊对照,干预90分钟,于8个时间点(基线、T0、T10、T30、T60、T90、T120、T210 min)行枸橼酸化高岭土肝素酶TEG检测。iREBOA因间歇全阻断与完全放气导致近端压力波动更大、峰值压力更高,但两组间所有TEG参数均无显著差异;两组随时间均出现凝血时间缩短(R时间P<0.001;K时间P<0.001)和凝块强度下降(MA P=0.01;G P=0.02)。作者结论认为,严重出血后pREBOA与iREBOA均可导致更快的凝血反应时间,但考虑pREBOA组输血需求显著减少、血流动力学更稳定,可能有证据支持优先使用pREBOA而非iREBOA。

要点

  • Yorkshire猪肝横断非控制性出血模型(每组n=8)中,pREBOA与iREBOA组间所有TEG参数均无显著差异。
  • iREBOA因间歇全阻断和完全放气,近端压力波动更大、峰值压力更高,与pREBOA不同。
  • 两组随时间均出现凝血时间缩短(R时间P<0.001;K时间P<0.001)和凝块强度下降(MA P=0.01;G P=0.02)。
  • 作者认为,考虑pREBOA组输血需求显著减少且血流动力学更稳定,可能有证据支持优先使用pREBOA而非iREBOA。

适用人群与场景

  • Yorkshire猪,经肝横断造成非控制性出血,随后接受90分钟自动化pREBOA、iREBOA或无球囊支持(对照),每组n=8。

处置流程与药物剂量

  • 自动化pREBOA维持部分阻断;自动化iREBOA将球囊从全阻断间歇滴定至无阻断;对照无球囊支持;干预时长90分钟。

研究设计与关键结果

  • 研究类型:高致死性猪出血模型实验;每组n=8,分pREBOA、iREBOA与对照三组。
  • iREBOA因间歇全阻断和完全放气,近端压力波动更大、峰值压力更高,与pREBOA不同。
  • 尽管急性血流动力学存在差异,iREBOA与pREBOA组间所有TEG参数均无显著差异。
  • 两组动物随时间均出现凝血时间缩短(R时间P<0.001;K时间P<0.001)和凝块强度下降(MA P=0.01;G P=0.02)。
  • 作者提到pREBOA组输血需求显著减少、血流动力学反应更稳定。

证据类型、等级与局限

  • 证据类型:动物实验(Yorkshire猪非控制性出血模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,考虑pREBOA组输血需求显著减少且血流动力学更稳定,可能有证据支持优先使用pREBOA而非iREBOA。
  • 严重出血后无论pREBOA还是iREBOA均可出现更快的凝血反应时间(R时间缩短),床旁TEG可见凝血时间缩短与凝块强度下降。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Death due to hemorrhagic shock, particularly, noncompressible truncal hemorrhage, remains one of the leading causes of potentially preventable deaths. Automated partial and intermittent resuscitative endovascular balloon occlusion of the aorta (i.e., pREBOA and iREBOA, respectively) are lifesaving endovascular strategies aimed to achieve quick hemostatic control while mitigating distal ischemia. In iREBOA, the balloon is titrated from full occlusion to no occlusion intermittently, whereas in pREBOA, a partial occlusion is maintained. Therefore, these two interventions impose different hemodynamic conditions, which may impact coagulation and the endothelial glycocalyx layer. In this study, we aimed to characterize the clotting kinetics and coagulopathy associated with iREBOA and pREBOA, using thromboelastography (TEG). We hypothesized that iREBOA would be associated with a more hypercoagulopathic response compared with pREBOA due to more oscillatory flow. Methods: Yorkshire swine (n = 8/group) were subjected to an uncontrolled hemorrhage by liver transection, followed by 90 min of automated pREBOA, iREBOA, or no balloon support (control). Hemodynamic parameters were continuously recorded, and blood samples were serially collected during the experiment (i.e., eight key time points: baseline (BL), T0, T10, T30, T60, T90, T120, T210 min). Citrated kaolin heparinase assays were run on a TEG 5000 (Haemonetics, Niles, IL). General linear mixed models were employed to compare differences in TEG parameters between groups and over time using STATA (v17; College Station, TX), while adjusting for sex and weight. Results: As expected, iREBOA was associated with more oscillations in proximal pressure (and greater magnitudes of peak pressure) because of the intermittent periods of full aortic occlusion and complete balloon deflation, compared to pREBOA. Despite these differences in acute hemodynamics, there were no significant differences in any of the TEG parameters between the iREBOA and pREBOA groups. However, animals in both groups experienced a significant reduction in clotting times (R time: P < 0.001; K time: P < 0.001) and clot strength (MA: P = 0.01; G: P = 0.02) over the duration of the experiment. Conclusions: Despite observing acute differences in peak proximal pressures between the iREBOA and pREBOA groups, we did not observe any significant differences in TEG parameters between iREBOA and pREBOA. The changes in TEG profiles were significant over time, indicating that a severe hemorrhage followed by both pREBOA and iREBOA can result in faster clotting reaction times (i.e., R times). Nevertheless, when considering the significant reduction in transfusion requirements and more stable hemodynamic response in the pREBOA group, there may be some evidence favoring pREBOA usage over iREBOA.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Renaldo AC, Soudan H, Gomez MK, et al. INVESTIGATING THE RELATIONSHIP BETWEEN BLEEDING, CLOTTING, AND COAGULOPATHY DURING AUTOMATED PARTIAL REBOA STRATEGIES IN A HIGHLY LETHAL PORCINE HEMORRHAGE MODEL. Shock. 2024. PMID: 38888571. doi:10.1097/SHK.0000000000002385

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。